Trial intelligence / Profile preview

Dexmedetomidine Nasal Spray for Perioperative Anxiety in Laparoscopic Cholecystectomy

ChiCTR2600129660Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of dexmedetomidine in preoperative anxiety and cholelithiasis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Preoperative anxiety score. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

preoperative anxietycholelithiasis

Beyond the preview

Go deeper on ChiCTR2600129660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600129660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call